Physician

Darren M. Traub, DO

Study Coordinator

Kyle McFadden
484-658-1802

Kyle.McFadden@sluhn.org

Close

Synopsis: DEFINE AFib is a prospective, observational, post-market clinical study administered to patients via the Medtronic Discovery app platform. The Study App is designed to easily collect data using an iPhone® and is built using the Apple® ResearchKit® framework. Interested participants will be screened through the Medtronic Discovery app and those eligible will complete an app-based informed consent. Participants will receive health-focused and quality of life surveys at variable timepoints. DEFINE AFib will measure healthcare interactions using administered surveys to identify said interactions. The Medtronic Discovery app will provide participants with a summary of their ICM data. Participants will be followed up to 5 years or to the end of their ICM service life.

Close

Inclusion Criteria

Patients with a LINQ ICM who have a self-reported history of AF and who have received an ICM for the following device-logged indications, categorized into the following discrete groups:

• Stroke: Cryptogenic stroke indication
• AF management: AF management and post-ablation management indications
• Suspected AF: Suspected AF and palpitations indications
• Individual Access and ability to use an Apple iPhone^® compatible with Medtronic's research app (iOS^® v. 13.X or higher)
• Patient is 22 years of age or older
• Located in the United States, with CareLink managed through servers located in United States (50 states or District of Columbia)
• Valid email address from self-report at enrollment
• Patient must be able to read and write in English

Close